189 related articles for article (PubMed ID: 34642332)
1. Association between Fusobacterium nucleatum and patient prognosis in metastatic colon cancer.
Lee JB; Kim KA; Cho HY; Kim D; Kim WK; Yong D; Lee H; Yoon SS; Han DH; Han YD; Paik S; Jang M; Kim HS; Ahn JB
Sci Rep; 2021 Oct; 11(1):20263. PubMed ID: 34642332
[TBL] [Abstract][Full Text] [Related]
2. Fusobacterium nucleatum associates with stages of colorectal neoplasia development, colorectal cancer and disease outcome.
Flanagan L; Schmid J; Ebert M; Soucek P; Kunicka T; Liska V; Bruha J; Neary P; Dezeeuw N; Tommasino M; Jenab M; Prehn JH; Hughes DJ
Eur J Clin Microbiol Infect Dis; 2014 Aug; 33(8):1381-90. PubMed ID: 24599709
[TBL] [Abstract][Full Text] [Related]
3. Fusobacterium nucleatum Increases Proliferation of Colorectal Cancer Cells and Tumor Development in Mice by Activating Toll-Like Receptor 4 Signaling to Nuclear Factor-κB, and Up-regulating Expression of MicroRNA-21.
Yang Y; Weng W; Peng J; Hong L; Yang L; Toiyama Y; Gao R; Liu M; Yin M; Pan C; Li H; Guo B; Zhu Q; Wei Q; Moyer MP; Wang P; Cai S; Goel A; Qin H; Ma Y
Gastroenterology; 2017 Mar; 152(4):851-866.e24. PubMed ID: 27876571
[TBL] [Abstract][Full Text] [Related]
4. Association of Fusobacterium nucleatum infection with the clinicopathological characteristics in colorectal cancer patients.
Pang SW; Armon S; Chook JB; Chew J; Peh KB; Lim WW; Peh SC; Teow SY
Mol Biol Rep; 2024 Jan; 51(1):124. PubMed ID: 38227097
[TBL] [Abstract][Full Text] [Related]
5. Invasive Fusobacterium nucleatum may play a role in the carcinogenesis of proximal colon cancer through the serrated neoplasia pathway.
Yu J; Chen Y; Fu X; Zhou X; Peng Y; Shi L; Chen T; Wu Y
Int J Cancer; 2016 Sep; 139(6):1318-26. PubMed ID: 27130618
[TBL] [Abstract][Full Text] [Related]
6.
Gethings-Behncke C; Coleman HG; Jordao HWT; Longley DB; Crawford N; Murray LJ; Kunzmann AT
Cancer Epidemiol Biomarkers Prev; 2020 Mar; 29(3):539-548. PubMed ID: 31915144
[TBL] [Abstract][Full Text] [Related]
7. Fusobacterium nucleatum as a prognostic marker of colorectal cancer in a Japanese population.
Yamaoka Y; Suehiro Y; Hashimoto S; Hoshida T; Fujimoto M; Watanabe M; Imanaga D; Sakai K; Matsumoto T; Nishioka M; Takami T; Suzuki N; Hazama S; Nagano H; Sakaida I; Yamasaki T
J Gastroenterol; 2018 Apr; 53(4):517-524. PubMed ID: 28823057
[TBL] [Abstract][Full Text] [Related]
8. Fusobacterium nucleatum and Clinicopathologic Features of Colorectal Cancer: Results From the ColoCare Study.
Eisele Y; Mallea PM; Gigic B; Stephens WZ; Warby CA; Buhrke K; Lin T; Boehm J; Schrotz-King P; Hardikar S; Huang LC; Pickron TB; Scaife CL; Viskochil R; Koelsch T; Peoples AR; Pletneva MA; Bronner M; Schneider M; Ulrich AB; Swanson EA; Toriola AT; Shibata D; Li CI; Siegel EM; Figueiredo J; Janssen KP; Hauner H; Round J; Ulrich CM; Holowatyj AN; Ose J
Clin Colorectal Cancer; 2021 Sep; 20(3):e165-e172. PubMed ID: 33935016
[TBL] [Abstract][Full Text] [Related]
9. Association of Fusobacterium nucleatum infection with colorectal cancer in Chinese patients.
Li YY; Ge QX; Cao J; Zhou YJ; Du YL; Shen B; Wan YJ; Nie YQ
World J Gastroenterol; 2016 Mar; 22(11):3227-33. PubMed ID: 27004000
[TBL] [Abstract][Full Text] [Related]
10. Invasive Fusobacterium nucleatum activates beta-catenin signaling in colorectal cancer via a TLR4/P-PAK1 cascade.
Chen Y; Peng Y; Yu J; Chen T; Wu Y; Shi L; Li Q; Wu J; Fu X
Oncotarget; 2017 May; 8(19):31802-31814. PubMed ID: 28423670
[TBL] [Abstract][Full Text] [Related]
11. [Advances on the treatment of
Wang H; Hou X; Liu J; Yang C
Sheng Wu Gong Cheng Xue Bao; 2023 Sep; 39(9):3670-3680. PubMed ID: 37805845
[No Abstract] [Full Text] [Related]
12. A Simple and Novel Fecal Biomarker for Colorectal Cancer: Ratio of
Guo S; Li L; Xu B; Li M; Zeng Q; Xiao H; Xue Y; Wu Y; Wang Y; Liu W; Zhang G
Clin Chem; 2018 Sep; 64(9):1327-1337. PubMed ID: 29914865
[TBL] [Abstract][Full Text] [Related]
13. Angiogenic and Antiangiogenic VEGFA Splice Variants in Colorectal Cancer: Prospective Retrospective Cohort Study in Patients Treated With Irinotecan-Based Chemotherapy and Bevacizumab.
Pentheroudakis G; Mavroeidis L; Papadopoulou K; Koliou GA; Bamia C; Chatzopoulos K; Samantas E; Mauri D; Efstratiou I; Pectasides D; Makatsoris T; Bafaloukos D; Papakostas P; Papatsibas G; Bombolaki I; Chrisafi S; Kourea HP; Petraki K; Kafiri G; Fountzilas G; Kotoula V
Clin Colorectal Cancer; 2019 Dec; 18(4):e370-e384. PubMed ID: 31402291
[TBL] [Abstract][Full Text] [Related]
14. Chemotherapy plus bevacizumab as an optimal first-line therapeutic treatment for patients with right-sided metastatic colon cancer: a meta-analysis of first-line clinical trials.
You XH; Jiang YH; Fang Z; Sun F; Li Y; Wang W; Xia ZJ; Wang XZ; Ying HQ
ESMO Open; 2020 Mar; 4(Suppl 2):. PubMed ID: 32132090
[TBL] [Abstract][Full Text] [Related]
15.
Ye X; Wang R; Bhattacharya R; Boulbes DR; Fan F; Xia L; Adoni H; Ajami NJ; Wong MC; Smith DP; Petrosino JF; Venable S; Qiao W; Baladandayuthapani V; Maru D; Ellis LM
Cancer Prev Res (Phila); 2017 Jul; 10(7):398-409. PubMed ID: 28483840
[TBL] [Abstract][Full Text] [Related]
16. Fusobacterium nucleatum detected simultaneously in a pyogenic liver abscess and advanced sigmoid colon cancer.
Shigefuku R; Watanabe T; Kanno Y; Ikeda H; Nakano H; Hattori N; Matsunaga K; Matsumoto N; Kanno SI; Nosho K; Hachiya A; Iwatani Y; Matsumori T; Tsukikawa S; Makizumi R; Otsubo T; Yamamoto H; Itoh F
Anaerobe; 2017 Dec; 48():144-146. PubMed ID: 28823592
[TBL] [Abstract][Full Text] [Related]
17. Fusobacterium nucleatum tumor DNA levels are associated with survival in colorectal cancer patients.
Kunzmann AT; Proença MA; Jordao HW; Jiraskova K; Schneiderova M; Levy M; Liska V; Buchler T; Vodickova L; Vymetalkova V; Silva AE; Vodicka P; Hughes DJ
Eur J Clin Microbiol Infect Dis; 2019 Oct; 38(10):1891-1899. PubMed ID: 31367996
[TBL] [Abstract][Full Text] [Related]
18. Comparison of 627 patients with right- and left-sided colon cancer in China: Differences in clinicopathology, recurrence, and survival.
Qin Q; Yang L; Sun YK; Ying JM; Song Y; Zhang W; Wang JW; Zhou AP
Chronic Dis Transl Med; 2017 Mar; 3(1):51-59. PubMed ID: 29063056
[TBL] [Abstract][Full Text] [Related]
19. The reduction of Fusobacterium nucleatum in mice is irrelevant to the nitric oxide induced by iNOS.
Kato C; Mikami M; Suzuki A; Saito K
Microbiol Immunol; 2003; 47(1):27-35. PubMed ID: 12636250
[TBL] [Abstract][Full Text] [Related]
20. Yttrium-90 Hepatic Radioembolization for Advanced Chemorefractory Metastatic Colorectal Cancer: Survival Outcomes Based on Right- Versus Left-Sided Primary Tumor Location.
Wu V; Li MD; Goodwin JS; Wehrenberg-Klee EP; Zurkiya O; Kalva SP; Ganguli S
AJR Am J Roentgenol; 2021 Nov; 217(5):1141-1152. PubMed ID: 33594907
[No Abstract] [Full Text] [Related]
[Next] [New Search]